Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Squamous Non-Small Cell Neoplasm of Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05870319
What this trial is testing

A Phase III Study of SKB264 for EGFR Mutant NSCLC Patients

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 376
Large-scale testing (Phase 3)Ended earlyNCT01282151
What this trial is testing

TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer

Who this might be right for
Carcinoma, Non Small Cell Lung
Chonnam National University Hospital 148
Not applicableUnknownNCT00122239
What this trial is testing

Gene Polymorphisms and Normal Tissue Radiation Injury in Patients Treated for Breast, Prostate, Brain, Lung, and Head and Neck Cancers

Who this might be right for
Breast CancerGliomaProstate Cancer+3 more
AHS Cancer Control Alberta 13
Early research (Phase 1)Study completedNCT00773188
What this trial is testing

A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 6
Testing effectiveness (Phase 2)Ended earlyNCT00369070
What this trial is testing

Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

Who this might be right for
Advanced Non-squamous NSCLC
Amgen 186
Post-approval studies (Phase 4)Looking for participantsNCT07405086
What this trial is testing

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

Who this might be right for
Advanced Biliary Tract CarcinomaAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Hepatocellular Carcinoma+18 more
OHSU Knight Cancer Institute 160
Testing effectiveness (Phase 2)WithdrawnNCT04944173
What this trial is testing

SCION: SABR and Checkpoint Inhibition of NSCLC

Who this might be right for
Non Small Cell Lung CancerCarcinoma, Non-Small-Cell LungNon-small Cell Lung Cancer Stage I+4 more
University of British Columbia
Early research (Phase 1)Study completedNCT04504669
What this trial is testing

First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid Tumours

Who this might be right for
Clear Cell Renal Cell CancerNon-Small-Cell Lung CancerTriple Negative Breast Neoplasms+6 more
AstraZeneca 60
Large-scale testing (Phase 3)Study completedNCT03196986
What this trial is testing

Mil60 Versus Bevacizumab in Patients With Treatment-naïve Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Beijing Mabworks Biotech Co., Ltd. 517
Early research (Phase 1)Study completedNCT01323062
What this trial is testing

Bavituximab Plus Carbo and Pemetrexed in Chemo-Naive Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Subjects

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
UNC Lineberger Comprehensive Cancer Center 26
Early research (Phase 1)Study completedNCT02364362
What this trial is testing

Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Jiangsu HengRui Medicine Co., Ltd. 18
Early research (Phase 1)Ended earlyNCT00288054
What this trial is testing

S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
SWOG Cancer Research Network 24
Large-scale testing (Phase 3)Study completedNCT02578680
What this trial is testing

Study of Pemetrexed+Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Participants With First Line Metastatic Nonsquamous Non-small Cell Lung Cancer (MK-3475-189/KEYNOTE-189)

Who this might be right for
Non-Small-Cell Lung Carcinoma
Merck Sharp & Dohme LLC 616
Testing effectiveness (Phase 2)Study completedNCT01059643
What this trial is testing

A Study in Ovarian, Non-Small Cell Lung, Prostate, Colorectal, Gastroesophageal Cancers, and Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Ovarian CancerNon Small Cell Lung CancerProstate Cancer+4 more
Eli Lilly and Company 103
Testing effectiveness (Phase 2)Ended earlyNCT03574818
What this trial is testing

Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001

Who this might be right for
Squamous Cell Lung Cancer
Montefiore Medical Center 1
Testing effectiveness (Phase 2)UnknownNCT02515435
What this trial is testing

The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Tongji University 40
Testing effectiveness (Phase 2)Ended earlyNCT05219578
What this trial is testing

RTX-224 Monotherapy in Patients With Solid Tumors

Who this might be right for
Non Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more
Rubius Therapeutics 7
Not applicableActive Not RecruitingNCT05644808
What this trial is testing

MYLUNG Consortium Study Protocol 2

Who this might be right for
Carcinoma, Non-Small-Cell Lung
US Oncology Research 1,002
Large-scale testing (Phase 3)Looking for participantsNCT06875310
What this trial is testing

Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Mirati Therapeutics Inc. 630
Large-scale testing (Phase 3)Study completedNCT01351415
What this trial is testing

Bevacizumab in Combination With Standard of Care Treatment in Participants With Advanced Non-squamous Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 485
Next Page